Scholar Rock scholarrock.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Scholar Rock is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation, resulting in therapeutic effects specifically at the source of disease. The company's proprietary technology has a unique capability for highly selective targeting of growth factors which play a fundamental role in regulating cell growth and differentiation. Modulating supracellular activation is rel...Show all

Scholar Rock is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation, resulting in therapeutic effects specifically at th...Show all

Company (Alive / Active)

Phone: 857-259-3860

Fax:

620 Memorial Drive
2nd Floor
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Scholar Rock $103M Jan 3, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Scholar Rock Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
ARCH Venture PartnersVenture CapitalChicago, Illinois, United StatesSeries C, Series B, Series A
Invus GroupAsset/Investment ManagementNew York, New York, United StatesSeries C
Fidelity InvestmentsDiversified Financial ServicesBoston, Massachusetts, United StatesSeries C, Series B
EcoR1 CapitalVenture CapitalSeries C, Series B, Series A
Cormorant Asset ManagementAsset/Investment ManagementBoston, Massachusetts, United StatesSeries C, Series B
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods for growth factor modulation Jun 20, 2016 Sep 12, 2017 Patent
Compositions and methods for growth factor modulation Jul 09, 2015 Sep 12, 2017 Patent
Compositions and methods for growth factor modulation Jul 09, 2015 Feb 28, 2017 Patent
Compositions and methods for growth factor modulation Jul 09, 2015 Feb 21, 2017 Patent
Compositions and methods for growth factor modulation Jul 09, 2015 Jul 26, 2016 Patent
See all 13 patents